Crinetics Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CRNX Key Statistics
Stock Snapshot
Crinetics Pharmaceuticals(CRNX) stock is priced at $84.13, giving the company a market capitalization of 8.85B. It carries a P/E multiple of -16.27.
On 2026-08-03, Crinetics Pharmaceuticals(CRNX) stock traded between a low of $83.47 and a high of $84.13. Shares are currently priced at $84.13, which is +0.8% above the low and 0.0% below the high.
The Crinetics Pharmaceuticals(CRNX)'s current trading volume is 1.86M, compared to an average daily volume of 3.1M.
In the last year, Crinetics Pharmaceuticals(CRNX) shares hit a 52-week high of $84.13 and a 52-week low of $25.83.
In the last year, Crinetics Pharmaceuticals(CRNX) shares hit a 52-week high of $84.13 and a 52-week low of $25.83.
CRNX News
Crinetics Pharma (CRNX) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confid...
Analyst ratings
92%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.